Veterinary Stereotactic Radiosurgery Systems Market Size and Outlook 2031

Report Description

Key Insights	Details
Forecast Period	2026 - 2031
Market Size (2025)	USD 3.69 Billion
CAGR (2026-2031)	11.28%
Fastest Growing Segment	Research institutions
Largest Market	North America
Market Size (2031)	USD 7.01 Billion

Market Overview

The Global Veterinary Stereotactic Radiosurgery Systems Market is expected to grow from USD 3.69 Billion in 2025 to USD 7.01 Billion by 2031 at a 11.28% CAGR. Veterinary stereotactic radiosurgery systems deliver highly precise, high-dose radiation to treat tumors in companion animals, aiming to minimize damage to surrounding healthy tissue. Key market drivers include the growing pet humanization trend, which leads owners to seek advanced medical interventions for their animals, and the increasing incidence of treatable cancers in pets. Additionally, the expanding availability of pet insurance supports market growth.

According to the North American Pet Health Insurance Association, in 2025, approximately 7 million pets were covered by insurance policies in the US. This financial support enables greater access to expensive treatments. However, a significant challenge impeding market expansion remains the substantial capital investment required for acquiring and maintaining these specialized radiosurgery systems.

Key Market Drivers

Rising Cancer Incidence in Companion Animals Drives SRS Demand
The rising incidence of cancer in companion animals is a primary driver fueling the Global Veterinary Stereotactic Radiosurgery Systems Market. As pets live longer due to advances in general veterinary care, the likelihood of developing age-related diseases, including various forms of cancer, increases significantly. This growing prevalence creates a substantial patient pool requiring advanced oncology treatments. According to the American Animal Hospital Association, in January 2026, cancer affects 50% of dogs and approximately 30% of cats over 10 years of age. This demographic shift necessitates sophisticated and precise treatment modalities like stereotactic radiosurgery to manage and treat tumors effectively, improving both prognosis and quality of life for these animals.

Increased Pet Owner Investment and Expansion of Oncology Infrastructure
Additionally, enhanced pet owner awareness and willingness to invest in advanced veterinary care critically influence market growth. The increasing humanization of pets leads owners to seek the highest standard of medical intervention, mirroring treatments available in human medicine. This emotional bond, coupled with greater awareness of treatment options, translates into a higher adoption rate for costly, specialized procedures such as stereotactic radiosurgery. According to U.S. consumer research from Elanco Animal Health, released in November 2026, 93% of pet owners surveyed spent the same amount or more on their pets over the preceding three months. This willingness to invest supports the expansion of specialized veterinary oncology services globally. Furthermore, the growth of infrastructure supporting such treatments is evident; according to PetCure Oncology, in May 2026, they had expanded to over 30 locations across North America, each equipped with state-of-the-art linear accelerators and treatment planning systems. This expansion reflects the market's response to the demand for advanced cancer therapies.

Download Free Sample Report

Key Market Challenges

High Upfront Costs Impede Adoption
The substantial capital investment required for acquiring and maintaining specialized veterinary stereotactic radiosurgery systems represents a significant impediment to the growth of the Global Veterinary Stereotactic Radiosurgery Systems Market. The high upfront cost associated with these advanced medical devices creates a considerable financial barrier for many veterinary practices, particularly smaller clinics or those operating with more constrained budgets. This financial outlay often includes the considerable purchase price of the equipment itself, specialized facility modifications, and ongoing maintenance contracts, all contributing to a substantial capital expenditure.

Cost Constraints Limit Accessibility and Adoption
Such high financial demands severely limit the accessibility of these systems to a broad range of veterinary establishments. According to the American Veterinary Medical Association's 2025 Census of Veterinarians, 26.3% of practice owners who reported falling behind on technology advancements attributed cost as the primary reason. While stereotactic radiosurgery systems represent a high-end technological investment beyond general practice technology, this statistic underscores the pervasive financial constraints within the industry that directly impede the adoption of costly specialized equipment. Consequently, the limited number of veterinary facilities capable of making such an investment restricts the overall market penetration and slows the broader availability of these advanced cancer treatments for companion animals.

Key Market Trends

AI-Driven Imaging Enhances Treatment Planning
The integration of advanced imaging and artificial intelligence (AI) in treatment planning represents a pivotal trend, enhancing the precision and efficiency of veterinary stereotactic radiosurgery systems. These technological advancements enable more accurate tumor localization, real-time adjustments during treatment, and highly individualized therapy protocols for complex cases. This capability allows veterinary oncologists to better differentiate cancerous tissue from healthy structures, minimizing collateral damage and improving therapeutic outcomes for companion animals. According to a joint study by Digitail and the American Animal Hospital Association, in their 2026 report, AI adoption in veterinary practices more than doubled from 39.2% in 2024 to 83.7% in 2026, indicating a broad embrace of intelligent tools that extend to sophisticated treatment planning.

Mobile and Compact Radiosurgery Expands Access
Another significant trend shaping the market is the emergence of mobile and compact radiosurgery systems, which address prior limitations related to facility requirements and capital expenditure. These smaller, more versatile units are designed to expand access to advanced radiation therapy by reducing the need for extensive infrastructure, such as dedicated radiation vaults, which are typically required for conventional large-scale systems. This increased accessibility allows more veterinary practices to offer specialized radiosurgery treatments, especially in regions where comprehensive facilities are scarce. PetCure Oncology, in its December 2024 discussion on trends for 2025, highlighted the value of compact, self-contained radiation therapy units, emphasizing that these systems do not require a dedicated radiation vault, thus transforming access to care.

Segmental Insights

Research Institutions Driving Growth and Innovation in Veterinary SRS
Research institutions represent the fastest-growing segment within the Global Veterinary Stereotactic Radiosurgery Systems Market. This rapid expansion stems from their pivotal role in advancing veterinary oncology through dedicated research and development efforts. These institutions are at the forefront of conducting clinical trials, exploring novel applications, and integrating advanced imaging and treatment planning technologies for animals. Their focus on precision in veterinary medicine, coupled with the critical function of training future veterinary specialists, directly accelerates the adoption and refinement of stereotactic radiosurgery techniques. This commitment to innovation ensures the continuous evolution of highly precise, non-invasive treatment options for companion animals, meeting the increasing demand for advanced care.

Regional Insights

North America as Market Leader Driven by Robust Veterinary Infrastructure and Investment in Precision Oncology
North America leads the global veterinary stereotactic radiosurgery systems market due to its highly developed veterinary infrastructure and substantial expenditure on pet healthcare. The region benefits from a robust network of specialized veterinary hospitals and oncology centers, which readily adopt advanced precision therapies for treating complex animal cancer cases. Furthermore, a significant increase in pet ownership and pet owners' willingness to invest in sophisticated treatments contribute to the market's strength. This is further supported by the presence of key technology providers and ongoing innovations in veterinary oncology, fostered by academic institutions and private practices.

Recent Developments

In December 2025, Empyrean Medical Systems and Thrive Pet Healthcare announced a partnership to introduce a new radiation therapy platform called Sirius into veterinary medicine. This robotically accelerated conformal beam radiation system, scheduled for debut in early 2026 at PetCure Oncology in Seattle, Washington, is engineered to deliver human-grade precision. It integrates robotic beam positioning, Monte Carlo–based treatment planning, and real-time image guidance to target tumors with high-dose radiation while protecting healthy tissue. This collaboration directly impacts the Global Veterinary Stereotactic Radiosurgery Systems Market by expanding access to advanced, precise cancer treatments for pets.
In September 2025, RaySearch Laboratories announced its plans to present µ-RayStation®, a specialized platform designed to support small animal irradiation research, at ASTRO 2025. This innovation in treatment planning software is aimed at advancing the capabilities for preclinical and translational studies in veterinary oncology. By providing sophisticated tools for precise radiation delivery and planning in small animal models, µ-RayStation® contributes to the development of new and improved stereotactic radiosurgery protocols for the Global Veterinary Stereotactic Radiosurgery Systems Market, fostering future clinical applications and research breakthroughs.
In September 2024, BluePearl Veterinary Hospital in Malvern, Pennsylvania, became the first veterinary clinic globally to employ CyberKnife technology for cancer treatment in animals. This non-invasive system, which delivers high-energy X-rays via a robot-mounted linear accelerator, offers precise radiation doses from various angles, targeting tumors while minimizing exposure to healthy surrounding tissues. The adoption of CyberKnife marks a significant advancement in the Global Veterinary Stereotactic Radiosurgery Systems Market by providing advanced capabilities for treating both cancerous and non-cancerous tumors and other conditions requiring radiation therapy in pets. This innovation aims to enhance treatment accuracy and patient outcomes.
In July 2024, breakthrough research detailed a neuro-oncologic veterinary trial utilizing Synchrotron Microbeam Radiation Therapy (MRT) for pet dogs diagnosed with glioma. This clinical transfer phase evaluated the feasibility and safety of delivering 3D-conformal, image-guided MRT with ultra-high-dose rate synchrotron X-ray microbeams. The study indicated that MRT did not induce acute to subacute radiotoxicity in normal brain tissues, significantly improved the quality of life for the dogs, and led to a notable reduction in tumor volume. This research represents a significant advancement in the Global Veterinary Stereotactic Radiosurgery Systems Market by exploring a novel, highly precise radiation modality for animal cancer treatment.

Key Market Players

Accuray Inc.
Elekta AB
PetCure Oncology
Xstrahl Ltd.
Varian Medical Systems Inc.
ViewRay Inc.
Siemens Healthineers AG
RefleXion Medical
ZAP Surgical Systems
Best Theratronics Ltd.

Product	Application	End User	Animal Type	Beam Technology	By Region
Linear Accelerator Systems More	Brain Tumours More	Veterinary Hospitals More	Companion Animals Equine Exotic & Small Mammals	Photon Beam More	North America Europe Asia Pacific South America Middle East & Africa

Report Scope:

In this report, the Global Veterinary Stereotactic Radiosurgery Systems Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Veterinary Stereotactic Radiosurgery Systems Market, Product:

Linear Accelerator Systems
More

Veterinary Stereotactic Radiosurgery Systems Market, Application:

Brain Tumours
More

Veterinary Stereotactic Radiosurgery Systems Market, End User:

Veterinary Hospitals
More

Veterinary Stereotactic Radiosurgery Systems Market, Animal Type:

Companion Animals
Equine
Exotic & Small Mammals

Veterinary Stereotactic Radiosurgery Systems Market, Beam Technology:

Photon Beam
More

Veterinary Stereotactic Radiosurgery Systems Market, By Region:

North America

United States
Canada
Mexico

Europe

France
United Kingdom
Italy
Germany
Spain

Asia Pacific

China
India
Japan
Australia
South Korea

South America

Brazil
Argentina
Colombia

Middle East & Africa

South Africa
Saudi Arabia
UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Veterinary Stereotactic Radiosurgery Systems Market.

Available Customizations:

Global Veterinary Stereotactic Radiosurgery Systems Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Global Veterinary Stereotactic Radiosurgery Systems Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at sales@techsciresearch.com

Table of content

1. Product Overview

1.1. Market Definition

1.2. Scope of the Market

1.2.1. Markets Covered

1.2.2. Years Considered for Study

1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study

2.2. Baseline Methodology

2.3. Key Industry Partners

2.4. Major Association and Secondary Sources

2.5. Forecasting Methodology

2.6. Data Triangulation & Validation

2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market

3.2. Overview of Key Market Segmentations

3.3. Overview of Key Market Players

3.4. Overview of Key Regions/Countries

3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Veterinary Stereotactic Radiosurgery Systems Market Outlook

5.1. Market Size & Forecast

5.1.1. By Value

5.2. Market Share & Forecast

5.2.1. Product (Linear Accelerator Systems, More)

5.2.2. Application (Brain Tumours, More)

5.2.3. End User (Veterinary Hospitals, More)

5.2.4. Animal Type (Companion Animals, Equine, Exotic & Small Mammals)

5.2.5. Beam Technology (Photon Beam, More)

5.2.6. By Region

5.2.7. By Company (2025)

5.3. Market Map

6. North America Veterinary Stereotactic Radiosurgery Systems Market Outlook

6.1. Market Size & Forecast

6.1.1. By Value

6.2. Market Share & Forecast

6.2.1. Product

6.2.2. Application

6.2.3. End User

6.2.4. Animal Type

6.2.5. Beam Technology

6.2.6. By Country

6.3. North America: Country Analysis

6.3.1. United States Veterinary Stereotactic Radiosurgery Systems Market Outlook

6.3.1.1. Market Size & Forecast

6.3.1.1.1. By Value

6.3.1.2. Market Share & Forecast

6.3.1.2.1. Product

6.3.1.2.2. Application

6.3.1.2.3. End User

6.3.1.2.4. Animal Type

6.3.1.2.5. Beam Technology

6.3.2. Canada Veterinary Stereotactic Radiosurgery Systems Market Outlook

6.3.2.1. Market Size & Forecast

6.3.2.1.1. By Value

6.3.2.2. Market Share & Forecast

6.3.2.2.1. Product

6.3.2.2.2. Application

6.3.2.2.3. End User

6.3.2.2.4. Animal Type

6.3.2.2.5. Beam Technology

6.3.3. Mexico Veterinary Stereotactic Radiosurgery Systems Market Outlook

6.3.3.1. Market Size & Forecast

6.3.3.1.1. By Value

6.3.3.2. Market Share & Forecast

6.3.3.2.1. Product

6.3.3.2.2. Application

6.3.3.2.3. End User

6.3.3.2.4. Animal Type

6.3.3.2.5. Beam Technology

7. Europe Veterinary Stereotactic Radiosurgery Systems Market Outlook

7.1. Market Size & Forecast

7.1.1. By Value

7.2. Market Share & Forecast

7.2.1. Product

7.2.2. Application

7.2.3. End User

7.2.4. Animal Type

7.2.5. Beam Technology

7.2.6. By Country

7.3. Europe: Country Analysis

7.3.1. Germany Veterinary Stereotactic Radiosurgery Systems Market Outlook

7.3.1.1. Market Size & Forecast

7.3.1.1.1. By Value

7.3.1.2. Market Share & Forecast

7.3.1.2.1. Product

7.3.1.2.2. Application

7.3.1.2.3. End User

7.3.1.2.4. Animal Type

7.3.1.2.5. Beam Technology

7.3.2. France Veterinary Stereotactic Radiosurgery Systems Market Outlook

7.3.2.1. Market Size & Forecast

7.3.2.1.1. By Value

7.3.2.2. Market Share & Forecast

7.3.2.2.1. Product

7.3.2.2.2. Application

7.3.2.2.3. End User

7.3.2.2.4. Animal Type

7.3.2.2.5. Beam Technology

7.3.3. United Kingdom Veterinary Stereotactic Radiosurgery Systems Market Outlook

7.3.3.1. Market Size & Forecast

7.3.3.1.1. By Value

7.3.3.2. Market Share & Forecast

7.3.3.2.1. Product

7.3.3.2.2. Application

7.3.3.2.3. End User

7.3.3.2.4. Animal Type

7.3.3.2.5. Beam Technology

7.3.4. Italy Veterinary Stereotactic Radiosurgery Systems Market Outlook

7.3.4.1. Market Size & Forecast

7.3.4.1.1. By Value

7.3.4.2. Market Share & Forecast

7.3.4.2.1. Product

7.3.4.2.2. Application

7.3.4.2.3. End User

7.3.4.2.4. Animal Type

7.3.4.2.5. Beam Technology

7.3.5. Spain Veterinary Stereotactic Radiosurgery Systems Market Outlook

7.3.5.1. Market Size & Forecast

7.3.5.1.1. By Value

7.3.5.2. Market Share & Forecast

7.3.5.2.1. Product

7.3.5.2.2. Application

7.3.5.2.3. End User

7.3.5.2.4. Animal Type

7.3.5.2.5. Beam Technology

8. Asia Pacific Veterinary Stereotactic Radiosurgery Systems Market Outlook

8.1. Market Size & Forecast

8.1.1. By Value

8.2. Market Share & Forecast

8.2.1. Product

8.2.2. Application

8.2.3. End User

8.2.4. Animal Type

8.2.5. Beam Technology

8.2.6. By Country

8.3. Asia Pacific: Country Analysis

8.3.1. China Veterinary Stereotactic Radiosurgery Systems Market Outlook

8.3.1.1. Market Size & Forecast

8.3.1.1.1. By Value

8.3.1.2. Market Share & Forecast

8.3.1.2.1. Product

8.3.1.2.2. Application

8.3.1.2.3. End User

8.3.1.2.4. Animal Type

8.3.1.2.5. Beam Technology

8.3.2. India Veterinary Stereotactic Radiosurgery Systems Market Outlook

8.3.2.1. Market Size & Forecast

8.3.2.1.1. By Value

8.3.2.2. Market Share & Forecast

8.3.2.2.1. Product

8.3.2.2.2. Application

8.3.2.2.3. End User

8.3.2.2.4. Animal Type

8.3.2.2.5. Beam Technology

8.3.3. Japan Veterinary Stereotactic Radiosurgery Systems Market Outlook

8.3.3.1. Market Size & Forecast

8.3.3.1.1. By Value

8.3.3.2. Market Share & Forecast

8.3.3.2.1. Product

8.3.3.2.2. Application

8.3.3.2.3. End User

8.3.3.2.4. Animal Type

8.3.3.2.5. Beam Technology

8.3.4. South Korea Veterinary Stereotactic Radiosurgery Systems Market Outlook

8.3.4.1. Market Size & Forecast

8.3.4.1.1. By Value

8.3.4.2. Market Share & Forecast

8.3.4.2.1. Product

8.3.4.2.2. Application

8.3.4.2.3. End User

8.3.4.2.4. Animal Type

8.3.4.2.5. Beam Technology

8.3.5. Australia Veterinary Stereotactic Radiosurgery Systems Market Outlook

8.3.5.1. Market Size & Forecast

8.3.5.1.1. By Value

8.3.5.2. Market Share & Forecast

8.3.5.2.1. Product

8.3.5.2.2. Application

8.3.5.2.3. End User

8.3.5.2.4. Animal Type

8.3.5.2.5. Beam Technology

9. Middle East & Africa Veterinary Stereotactic Radiosurgery Systems Market Outlook

9.1. Market Size & Forecast

9.1.1. By Value

9.2. Market Share & Forecast

9.2.1. Product

9.2.2. Application

9.2.3. End User

9.2.4. Animal Type

9.2.5. Beam Technology

9.2.6. By Country

9.3. Middle East & Africa: Country Analysis

9.3.1. Saudi Arabia Veterinary Stereotactic Radiosurgery Systems Market Outlook

9.3.1.1. Market Size & Forecast

9.3.1.1.1. By Value

9.3.1.2. Market Share & Forecast

9.3.1.2.1. Product

9.3.1.2.2. Application

9.3.1.2.3. End User

9.3.1.2.4. Animal Type

9.3.1.2.5. Beam Technology

9.3.2. UAE Veterinary Stereotactic Radiosurgery Systems Market Outlook

9.3.2.1. Market Size & Forecast

9.3.2.1.1. By Value

9.3.2.2. Market Share & Forecast

9.3.2.2.1. Product

9.3.2.2.2. Application

9.3.2.2.3. End User

9.3.2.2.4. Animal Type

9.3.2.2.5. Beam Technology

9.3.3. South Africa Veterinary Stereotactic Radiosurgery Systems Market Outlook

9.3.3.1. Market Size & Forecast

9.3.3.1.1. By Value

9.3.3.2. Market Share & Forecast

9.3.3.2.1. Product

9.3.3.2.2. Application

9.3.3.2.3. End User

9.3.3.2.4. Animal Type

9.3.3.2.5. Beam Technology

10. South America Veterinary Stereotactic Radiosurgery Systems Market Outlook

10.1. Market Size & Forecast

10.1.1. By Value

10.2. Market Share & Forecast

10.2.1. Product

10.2.2. Application

10.2.3. End User

10.2.4. Animal Type

10.2.5. Beam Technology

10.2.6. By Country

10.3. South America: Country Analysis

10.3.1. Brazil Veterinary Stereotactic Radiosurgery Systems Market Outlook

10.3.1.1. Market Size & Forecast

10.3.1.1.1. By Value

10.3.1.2. Market Share & Forecast

10.3.1.2.1. Product

10.3.1.2.2. Application

10.3.1.2.3. End User

10.3.1.2.4. Animal Type

10.3.1.2.5. Beam Technology

10.3.2. Colombia Veterinary Stereotactic Radiosurgery Systems Market Outlook

10.3.2.1. Market Size & Forecast

10.3.2.1.1. By Value

10.3.2.2. Market Share & Forecast

10.3.2.2.1. Product

10.3.2.2.2. Application

10.3.2.2.3. End User

10.3.2.2.4. Animal Type

10.3.2.2.5. Beam Technology

10.3.3. Argentina Veterinary Stereotactic Radiosurgery Systems Market Outlook

10.3.3.1. Market Size & Forecast

10.3.3.1.1. By Value

10.3.3.2. Market Share & Forecast

10.3.3.2.1. Product

10.3.3.2.2. Application

10.3.3.2.3. End User

10.3.3.2.4. Animal Type

10.3.3.2.5. Beam Technology

11. Market Dynamics

11.1. Drivers

11.2. Challenges

12. Market Trends & Developments

12.1. Merger & Acquisition (If Any)

12.2. Product Launches (If Any)

12.3. Recent Developments

13. Global Veterinary Stereotactic Radiosurgery Systems Market: SWOT Analysis

14. Porter's Five Forces Analysis

14.1. Competition in the Industry

14.2. Potential of New Entrants

14.3. Power of Suppliers

14.4. Power of Customers

14.5. Threat of Substitute Products

15. Competitive Landscape

15.1. Accuray Inc.

15.1.1. Business Overview

15.1.2. Products & Services

15.1.3. Recent Developments

15.1.4. Key Personnel

15.1.5. SWOT Analysis

15.2. Elekta AB

15.3. PetCure Oncology

15.4. Xstrahl Ltd.

15.5. Varian Medical Systems Inc.

15.6. ViewRay Inc.

15.7. Siemens Healthineers AG

15.8. RefleXion Medical

15.9. ZAP Surgical Systems

15.10. Best Theratronics Ltd.

16. Strategic Recommendations

17. About Us & Disclaimer

Report Description

Table of content

Figures and Tables

Frequently asked questions

What was the market size of the Global Veterinary Stereotactic Radiosurgery Systems Market in 2025?

Which is the dominating region in the Global Veterinary Stereotactic Radiosurgery Systems Market?

Which is the fastest growing segment in the Global Veterinary Stereotactic Radiosurgery Systems Market?

What is the expected growth rate of the Global Veterinary Stereotactic Radiosurgery Systems Market?